The COVID-19 Treatment Guidelines were developed to provide clinicians with guidance on caring for
patients with COVID-19. Because clinical information about the optimal management of COVID-19
is evolving quickly, these Guidelines are updated frequently to reflect newly published data and other
authorita...
Adler, Jeremy;
Ananthakrishnan, Ashwin N;
Chachu, Karen A;
Cohen, Benjamin L;
Nguyen, Nghia H;
Siddique, Shazia M;
Singh, Siddharth;
Sultan, Shahnaz;
Velayos, Fernando S;
Weiss, Jennifer M.
Biomarkers are used frequently for evaluation and monitoring of patients with Crohn’s disease (CD). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the management of CD.
A multidisciplinary panel of content ...
To provide recommendations for the management of premenstrual syndrome and premenstrual dysphoric disorder, collectively referred to as premenstrual disorders, based on assessment of the evidence regarding the safety and efficacy of available treatment options. An overview of the epidemiology, pathophysi...
The elimination of hepatitis C is a national priority (https://www.hhs.gov/sites/default/files/Viral-Hepatitis-NationalStrategic-Plan-2021-2025.pdf). During 2010–2021, hepatitis C virus (HCV) acute and chronic infections (hereinafter referred
to as HCV infections) increased in the United States, conseq...
Exocrine pancreatic insufficiency (EPI) is a disorder caused by the failure of the pancreas to deliver a minimum/
threshold level of specific pancreatic digestive enzymes to the
intestine, leading to the maldigestion of nutrients and macronutrients, resulting in their variable deficiencies. EPI is freque...
Neumann, Ignacio;
Izcovich, Ariel;
Aguilar, Ricardo;
Basantes, Guillermo León;
Casais, Patricia;
Colorio, Cecilia C;
Esposito, María Cecilia Guillermo;
Lázaro, Pedro P. García;
Pereira, Jaime;
García, Luis A. Meillon;
Rezende, Suely Meireles;
Serrano, Juan Carlos;
Valle, Mario L. Tejerina;
Altuna, Diana;
Zúñiga, Pamela;
Vera, Felipe;
Karzulovic, Lorena;
Schünemann, Holger J.
Implementation of international guidelines in Latin American settings requires additional considerations (ie, values and preferences, resources, accessibility, feasibility, and impact on health equity). The purpose of this guideline is to provide evidence-based recommendations about the diagnosis of veno...
To provide updated evidence-based recommendations for the treatment of postmenopausal osteoporosis. This guideline was developed using an a priori protocol in conjunction with a writing team consisting of two specialists in obstetrics and gynecology appointed by the ACOG Committee on Clinical Practice Gu...
To provide updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint (TMJ) arthritis, and systemic JIA with and without macrophage activation syndrome. Recommendations regarding tapering and discontinuing treat...
En la actualidad, las guías basadas en la evidencia constituyen una de las herramientas más útiles para mejorar la salud pública y la práctica clínica. Su finalidad es formular intervenciones con sólidas pruebas de eficacia, evitar riesgos innecesarios, utilizar los recursos de forma eficiente, di...
Rovin, Brad;
Adler, sharon;
Barratt, Jonathan;
Bridoux, Frank;
Burdge, Kelly;
Chan, Tak;
Cook, Terence;
Fervenza, Fernando;
Gibson, Keisha;
Glassock, Richard;
Earley, Amy;
Floege, Jürgen.
The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline. The aim is to assist clinicians caring for individuals with glomerulonephritis (GN), both adults and children. The scope includes various g...
